{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:04Z","timestamp":1794047464167,"version":"4.8.0"},"reference-count":7,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284942","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T05:35:32Z","timestamp":1711604132000},"page":"3078-3080","source":"Crossref","is-referenced-by-count":1,"title":["Clonal CD8&lt;sup&gt;+&lt;\/sup&gt; T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma"],"prefix":"10.3324","volume":"109","author":[{"given":"Roman","family":"Krzysiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bitoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakiba","family":"Belkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Hacein-Bey-Abina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"66351","doi-asserted-by":"crossref","unstructured":"Friedrich MJ, Neri P, Kehl N. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. 2023; 41(4):711-725.","DOI":"10.1016\/j.ccell.2023.02.008"},{"key":"66352","doi-asserted-by":"crossref","unstructured":"Moreau P, Garfall AL, van de Donk NWCJ. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022; 387(6):495-505.","DOI":"10.1056\/NEJMoa2203478"},{"key":"66353","doi-asserted-by":"crossref","unstructured":"Lesokhin AM, Tomasson MH, Arnulf B. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results. Nat Med. 2023; 29(9):2259-2267.","DOI":"10.1038\/s41591-023-02528-9"},{"key":"66354","doi-asserted-by":"crossref","unstructured":"Bahlis NJ, Raje NS, Costello C. Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM). J Clin Oncol. 2021; 39(Suppl 15):8006.","DOI":"10.1200\/JCO.2021.39.15_suppl.8006"},{"key":"66355","doi-asserted-by":"crossref","unstructured":"Jakubowiak AJ, Bahlis NJ, Raje NS. Elranatamab, a BCMA-targeted T-cell redirecting immunotherapy, for patients with relapsed or refractory multiple myeloma: updated results from MagnetisMM-1. J Clin Oncol. 2022; 40(Suppl 16):8014.","DOI":"10.1200\/JCO.2022.40.16_suppl.8014"},{"key":"66356","doi-asserted-by":"crossref","unstructured":"Wieland A, Kamphorst AO, Adsay NV. T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Cancer Immunol Immunother. 2018; 67(11):1767-1776.","DOI":"10.1007\/s00262-018-2228-7"},{"key":"66357","doi-asserted-by":"crossref","unstructured":"Subudhi SK, Aparicio A, Gao J. Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. Proc Natl Acad Sci U S A. 2016; 113(42):11919-11924.","DOI":"10.1073\/pnas.1611421113"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284942\/76838","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284942\/77454","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11525\/76838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:04Z","timestamp":1794045964000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":7,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284942","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,28]]}}}